Coelho et al. also demonstrated that the intracellular distribution and enzymatic activities of HK2 and PFK1 were positively correlated with the aggressiveness and invasiveness of different breast carcinoma subtypes, highlighting the great potential of these enzymes as prognostic biomarkers in breast cancer [92]. The gene discussed is HK2; the disease is breast cancer.